- Home
- PCVX vs ATI Comparison
PCVX vs ATI Comparison
Compare PCVX & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- ATI
- Stock Information
- Founded
- PCVX 2013
- ATI 1960
- Country
- PCVX United States
- ATI United States
- Employees
- PCVX N/A
- ATI N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- ATI Steel/Iron Ore
- Sector
- PCVX Health Care
- ATI Industrials
- Exchange
- PCVX Nasdaq
- ATI Nasdaq
- Market Cap
- PCVX 12.5B
- ATI 8.4B
- IPO Year
- PCVX 2020
- ATI N/A
- Fundamental
- Price
- PCVX $117.73
- ATI $64.40
- Analyst Decision
- PCVX Strong Buy
- ATI Strong Buy
- Analyst Count
- PCVX 7
- ATI 8
- Target Price
- PCVX $147.50
- ATI $74.00
- AVG Volume (30 Days)
- PCVX 1.5M
- ATI 1.5M
- Earning Date
- PCVX 11-04-2024
- ATI 10-31-2024
- Dividend Yield
- PCVX N/A
- ATI N/A
- EPS Growth
- PCVX N/A
- ATI N/A
- EPS
- PCVX N/A
- ATI 2.65
- Revenue
- PCVX N/A
- ATI $4,227,800,000.00
- Revenue This Year
- PCVX N/A
- ATI $8.08
- Revenue Next Year
- PCVX N/A
- ATI $8.96
- P/E Ratio
- PCVX N/A
- ATI $24.42
- Revenue Growth
- PCVX N/A
- ATI 2.45
- 52 Week Low
- PCVX $44.20
- ATI $35.03
- 52 Week High
- PCVX $121.06
- ATI $68.92
- Technical
- Relative Strength Index (RSI)
- PCVX 78.90
- ATI 58.34
- Support Level
- PCVX $113.56
- ATI $60.66
- Resistance Level
- PCVX $121.06
- ATI $63.09
- Average True Range (ATR)
- PCVX 4.94
- ATI 2.15
- MACD
- PCVX 0.46
- ATI 0.32
- Stochastic Oscillator
- PCVX 75.21
- ATI 89.92
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About ATI ATI Inc.
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several major end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.